GRCE · Grace Therapeutics, Inc.
Market Cap
$44.18M
Shares
21.04M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1444192
CUSIP
00439U104
13F (30d)
27 filings
27 filers
Visit website
Investor relations